D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 74 Citations 18,290 462 World Ranking 15234 National Ranking 631

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

His primary areas of study are Cancer research, Leukemia, Apoptosis, Immunology and Myeloid leukemia. His Cancer research research is multidisciplinary, incorporating elements of Cancer, Cell culture, In vitro, Downregulation and upregulation and Proteasome. His research integrates issues of Haematopoiesis, Stem cell, Cell growth, Myeloid and Biological activity in his study of Leukemia.

Aaron D. Schimmer focuses mostly in the field of Apoptosis, narrowing it down to topics relating to Cell biology and, in certain cases, GLUT1 and Snf3. The various areas that Aaron D. Schimmer examines in his Immunology study include Internal medicine, Disease and Cellular differentiation. His Myeloid leukemia study integrates concerns from other disciplines, such as Molecular biology, UBA1 and Gene knockdown.

His most cited work include:

  • Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia (918 citations)
  • Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice (413 citations)
  • Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. (378 citations)

What are the main themes of his work throughout his whole career to date?

Aaron D. Schimmer mainly investigates Internal medicine, Cancer research, Myeloid leukemia, Leukemia and Pharmacology. His Internal medicine research integrates issues from Gastroenterology, Surgery and Oncology. He combines subjects such as Cancer, Cell cycle, Apoptosis, Cyclin D2 and Immunology with his study of Cancer research.

He has included themes like Molecular biology and Cell biology in his Apoptosis study. His study brings together the fields of Gene knockdown and Myeloid leukemia. His work in Leukemia covers topics such as Stem cell which are related to areas like Mitochondrion.

He most often published in these fields:

  • Internal medicine (29.32%)
  • Cancer research (33.98%)
  • Myeloid leukemia (31.65%)

What were the highlights of his more recent work (between 2017-2021)?

  • Myeloid leukemia (31.65%)
  • Cancer research (33.98%)
  • Cell biology (17.28%)

In recent papers he was focusing on the following fields of study:

Myeloid leukemia, Cancer research, Cell biology, Internal medicine and Stem cell are his primary areas of study. The study incorporates disciplines such as DNA damage, Gene knockdown, Nucleoside analogue, Respiratory chain and Metabolism in addition to Myeloid leukemia. His Cancer research research includes elements of UBA1, Ubiquitin, Oxidative phosphorylation, Leukemia and In vivo.

His Leukemia study incorporates themes from Myeloid, Unfolded protein response and Clonogenic assay. His study on Mitochondrion is often connected to Intermembrane space as part of broader study in Cell biology. When carried out as part of a general Internal medicine research project, his work on Induction chemotherapy, Chemotherapy regimen and Chemotherapy is frequently linked to work in In patient, therefore connecting diverse disciplines of study.

Between 2017 and 2021, his most popular works were:

  • Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality (59 citations)
  • Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality (59 citations)
  • Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response (39 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

Aaron D. Schimmer mainly focuses on Cell biology, Myeloid leukemia, Mitochondrion, Cancer research and Stem cell. His Cell biology study incorporates themes from Regulator, Cytotoxic T cell, Tafazzin and Protease. His Myeloid leukemia research includes themes of Transcript level, Disease monitoring, After treatment, Complete remission and Respiratory chain.

His Mitochondrion study combines topics from a wide range of disciplines, such as Apoptosis, Mitochondrial matrix and Neurotoxicity. Aaron D. Schimmer does research in Cancer research, focusing on Myeloid specifically. His study in Stem cell is interdisciplinary in nature, drawing from both Cell culture and Pyruvate dehydrogenase complex.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia

Liran I. Shlush;Sasan Zandi;Amanda Mitchell;Weihsu Claire Chen.
Nature (2014)

1369 Citations

Inhibitor of Apoptosis Proteins: Translating Basic Knowledge into Clinical Practice

Aaron D. Schimmer.
Cancer Research (2004)

667 Citations

Anoikis resistance and tumor metastasis.

Craig D. Simpson;Craig D. Simpson;Kika Anyiwe;Kika Anyiwe;Aaron D. Schimmer;Aaron D. Schimmer.
Cancer Letters (2008)

633 Citations

Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia

Marko Škrtić;Shrivani Sriskanthadevan;Bozhena Jhas;Marinella Gebbia.
Cancer Cell (2011)

546 Citations

A 17-gene stemness score for rapid determination of risk in acute leukaemia

Stanley W. K. Ng;Amanda Mitchell;James A. Kennedy;James A. Kennedy;James A. Kennedy;Weihsu C. Chen.
Nature (2016)

541 Citations

Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity.

Aaron D. Schimmer;Kate Welsh;Clemencia Pinilla;Zhiliang Wang.
Cancer Cell (2004)

538 Citations

Myelodysplastic syndromes: the complexity of stem-cell diseases

Seth J. Corey;Mark D. Minden;Dwayne L. Barber;Hagop M Kantarjian.
Nature Reviews Cancer (2007)

426 Citations

Targeting XIAP for the treatment of malignancy

A D Schimmer;S Dalili;S Dalili;R A Batey;S J Riedl.
Cell Death & Differentiation (2006)

376 Citations

Novel Proteasome Inhibitors to Overcome Bortezomib Resistance

Amy M. Ruschak;Malik Slassi;Lewis E. Kay;Aaron D. Schimmer.
Journal of the National Cancer Institute (2011)

306 Citations

Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells.

Olga Berezovskaya;Aaron D. Schimmer;Anna B. Glinskii;Clemencia Pinilla.
Cancer Research (2005)

290 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Aaron D. Schimmer

Simone Fulda

Simone Fulda

Goethe University Frankfurt

Publications: 51

Marina Konopleva

Marina Konopleva

The University of Texas MD Anderson Cancer Center

Publications: 48

John E. Dick

John E. Dick

Princess Margaret Cancer Centre

Publications: 48

John C. Reed

John C. Reed

Sanford Burnham Prebys Medical Discovery Institute

Publications: 46

Vikas Gupta

Vikas Gupta

Princess Margaret Cancer Centre

Publications: 46

Hagop M. Kantarjian

Hagop M. Kantarjian

The University of Texas MD Anderson Cancer Center

Publications: 40

Michael Andreeff

Michael Andreeff

The University of Texas MD Anderson Cancer Center

Publications: 37

Linda Z. Penn

Linda Z. Penn

University of Toronto

Publications: 36

Mark D. Minden

Mark D. Minden

Princess Margaret Cancer Centre

Publications: 34

Seishi Ogawa

Seishi Ogawa

Kyoto University

Publications: 34

Ross L. Levine

Ross L. Levine

Memorial Sloan Kettering Cancer Center

Publications: 32

Michael B. Sporn

Michael B. Sporn

Dartmouth College

Publications: 31

Farhad Ravandi

Farhad Ravandi

The University of Texas MD Anderson Cancer Center

Publications: 23

Martin S. Tallman

Martin S. Tallman

Memorial Sloan Kettering Cancer Center

Publications: 23

Lars Bullinger

Lars Bullinger

Charité - University Medicine Berlin

Publications: 22

Gerrit Jansen

Gerrit Jansen

Amsterdam UMC

Publications: 22

Trending Scientists

Dervis Karaboga

Dervis Karaboga

Erciyes University

Lyle H. Ungar

Lyle H. Ungar

University of Pennsylvania

Gerd Wagner

Gerd Wagner

Brandenburg University of Technology

Clifford A. Pickover

Clifford A. Pickover

IBM (United States)

Stefan Minner

Stefan Minner

Technical University of Munich

Tsutomu Arakawa

Tsutomu Arakawa

Amgen (United States)

Qingshen Jing

Qingshen Jing

University of Cambridge

Ger J. M. Pruijn

Ger J. M. Pruijn

Radboud University Nijmegen

Kinji Ohno

Kinji Ohno

Nagoya University

Carlos Hermosilla

Carlos Hermosilla

University of Giessen

Robert Dudler

Robert Dudler

University of Zurich

Reinhard Hohlfeld

Reinhard Hohlfeld

Ludwig-Maximilians-Universität München

W. van den Brink

W. van den Brink

University of Amsterdam

Gilles E. Gignac

Gilles E. Gignac

University of Western Australia

Louis J. Soslowsky

Louis J. Soslowsky

University of Pennsylvania

Maximilian Stritzinger

Maximilian Stritzinger

Aarhus University

Something went wrong. Please try again later.